Marco Merlano

p53 polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosis

Daniele Bergamaschi, Milena Gasco, Louise Hiller et al. · Cancer Cell · 2003 · 456 citations · Full text

Tumor Biology, Oncology, Medicine +11

Treatment of Advanced Squamous-Cell Carcinoma of the Head and Neck with Alternating Chemotherapy and Radiotherapy

Marco Merlano, Vito Vitale, Riccardo Rosso et al. · New England Journal of Medicine · 1992 · 303 citations · Full text

Five-Year Update of a Randomized Trial of Alternating Radiotherapy and Chemotherapy Compared With Radiotherapy Alone in Treatment of Unresectable Squamous Cell Carcinoma of the Head and Neck

Marco Merlano, Marco Benasso, Renzo Corvò et al. · JNCI Journal of the National Cancer Institute · 1996 · 249 citations

Prospective evaluation of major vascular events in patients with nonsmall cell lung carcinoma treated with cisplatin and gemcitabine

Gianmauro Numico, Ornella Garrone, Vincenzo Dongiovanni et al. · Cancer · 2005 · 197 citations

Chemoradiotherapy with or without panitumumab in patients with unresected, locally advanced squamous-cell carcinoma of the head and neck (CONCERT-1): a randomised, controlled, open-label phase 2 trial

Michael Henke, A. Fortin, Heikki Minn et al. · The Lancet Oncology · 2015 · 161 citations

Open-label Phase 2, Radiation Therapy, Neoadjuvant Therapy +10